American National Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.6K | Buy |
80
+67
| +515% | +$29.8K | ﹤0.01% | 415 |
|
|
2025
Q1 | $6.3K | Buy |
13
+2
| +18% | +$970 | ﹤0.01% | 494 |
|
|
2024
Q4 | $4.43K | Hold |
11
| – | – | ﹤0.01% | 466 |
|
|
2024
Q3 | $5.12K | Hold |
11
| – | – | ﹤0.01% | 433 |
|
|
2024
Q2 | $5.16K | Hold |
11
| – | – | ﹤0.01% | 494 |
|
|
2024
Q1 | $4.6K | Sell |
11
-63
| -85% | -$26.3K | ﹤0.01% | 444 |
|
|
2023
Q4 | $30.1K | Sell |
74
-24
| -24% | -$9.77K | ﹤0.01% | 330 |
|
|
2023
Q3 | $34.1K | Buy |
98
+3
| +3% | +$1.04K | 0.01% | 313 |
|
|
2023
Q2 | $33.4K | Sell |
95
-6
| -6% | -$2.11K | 0.01% | 316 |
|
|
2023
Q1 | $31.8K | Sell |
101
-10
| -9% | -$3.15K | 0.01% | 316 |
|
|
2022
Q4 | $32K | Buy |
111
+54
| +95% | +$15.6K | 0.01% | 298 |
|
|
2022
Q3 | $17K | Buy |
57
+8
| +16% | +$2.39K | ﹤0.01% | 327 |
|
|
2022
Q2 | $14K | Hold |
49
| – | – | ﹤0.01% | 276 |
|
|
2022
Q1 | $13K | Buy |
49
+38
| +345% | +$10.1K | ﹤0.01% | 291 |
|
|
2021
Q4 | $2K | Hold |
11
| – | – | ﹤0.01% | 329 |
|
|
2021
Q3 | $2K | Hold |
11
| – | – | ﹤0.01% | 279 |
|
|
2021
Q2 | $2K | Hold |
11
| – | – | ﹤0.01% | 275 |
|
|
2021
Q1 | $2K | Buy |
+11
| New | +$2K | ﹤0.01% | 260 |
|
|
2017
Q1 | – | Sell |
-9
| Closed | -$1K | – | 325 |
|
|
2016
Q4 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 278 |
|